GSK's $30B US Investment: A New Era for Pharma?

GSK bets big on the USA! A massive $30 billion investment is coming to US research, development, and manufacturing, including a brand-new Pennsylvania factory. Is this a strategic move to dodge Trump's potential pharma tariffs, or a genuine commitment to US innovation? Find out how GSK's plan will create jobs, boost medical advancements, and potentially reshape the pharmaceutical landscape. Hosted on Acast. See acast.com/privacy for more information.